Loading...
Market
Public health agency to support Knapp & Bhargava study by end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official statements from agencies like WHO, CDC, or NIH
Story
Study by Drs. Knapp and Bhargava Finds More Hospitalizations for mRNA Vaccine Adverse Events Than COVID-19 Infections
Oct 20, 2024, 06:58 AM
A recent study led by leading American researchers Drs. Johannes D. Knapp and Aditi Bhargava, PhD, has found that hospitals treated significantly more patients for adverse events related to mRNA COVID-19 vaccines compared to unvaccinated patients with COVID-19 infections. This study highlights concerns about the safety of mRNA vaccines, which have been widely promoted by public health agencies. The findings have sparked discussions about the potential biases of US public health agencies in favoring mRNA vaccines over other types, such as Novavax and Janssen.
View original story
Similar markets
WHO • 25%
CDC • 25%
Other • 25%
None • 25%
Increased oversight on research funding • 25%
Reevaluation of pandemic response strategies • 25%
Improved fraud prevention measures • 25%
Public communication and trust-building • 25%
Closure of Khushi Juice Corner • 25%
Fines imposed • 25%
New regulations on juice vendors • 25%
No action taken • 25%
Yes • 50%
No • 50%
Study published • 25%
NIH takes action • 25%
Congressional hearing held • 25%
No significant outcome • 25%
Update vaccination guidelines • 25%
Initiate new studies • 25%
Issue a public warning • 25%
No significant action • 25%
Safety protocols • 25%
Funding usage • 25%
Research ethics • 25%
No significant review • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
No action taken • 25%
Fines imposed • 25%
Criminal charges filed • 25%
Other outcomes • 25%